← 治験一覧に戻る
日本における早期糖尿病介入研究
基本情報
- NCT ID
- NCT00464594
- ステータス
- 不明
- 試験のフェーズ
- 該当なし
- 試験タイプ
- 介入
- 目標被験者数
- 2,560
- 治験依頼者名
- Japan Early Diabetes Intervention Study Group
概要
The purpose of this study is to compare the suppressive effect of two kinds of interventions on the worsening/progression to definite diabetes: standard lifestyle guidance and standard lifestyle guidance combined with pharmacological intervention (monotherapy with one of acarbose, metformin, or gliclazide).
対象疾患
Diabetes Mellitus
介入
Standard lifestyle guidance(BEHAVIORAL)
Lifestyle guidance and monotherapy with acarbose(DRUG)
Lifestyle guidance and monotherapy with metformin(DRUG)
Lifestyle guidance and monotherapy with gliclazide(DRUG)
依頼者(Sponsor)
実施施設 (1)
東京科学大学病院
Tokyo, Japan(RECRUITING)